AN ACT RELATING TO COMMERCIAL LAW -- GENERAL REGULATORY PROVISIONS -- DECEPTIVE TRADE PRACTICES
This bill prohibits pharmacy benefits managers from engaging in specific deceptive trade practices, such as hidden payment reductions, steering patients toward affiliated pharmacies, or using patient data to gain economic control over pharmacies. It directly affects pharmacy benefits managers, pharmacists, pharmacies, and healthcare enrollees by defining and banning actions like spread pricing, unfair inducements, and restrictive refill policies for maintenance medications. The legislation also forbids PBMs from exploiting prescription data for marketing or repackaging drugs to extract price markups without informing patients. Violations of these rules are classified as unfair competition, and each individual transaction involving a prohibited act is considered a separate offense.
Bill status
died
1 of 4 stages cleared
Introduction
May 2026
Committee Review
Floor Vote
Governor
Introduced May 5, 2026
Last action May 21, 2026
Floor votes
How they voted
No floor votes recorded yet.
Full legislative history
Actions timeline
Total actions
3
Key actions
0
Committee
1
May 21, 2026
Committee
05/21/2026 Committee recommended measure be held for further study
legislature
May 5, 2026
Introduced
05/05/2026 Introduced, referred to Senate Health and Human Services
upper
5 primary · 0 co-sponsors
Sponsors
Role
Legislator
Party
State
District
P
Bob Britto
DDemocratic
P
Jake Bissaillon
DDemocratic
P
Lou DiPalma
DDemocratic
P
Mark McKenney
DDemocratic
P
Sue Sosnowski
DDemocratic
Ask Maddy
·
AI policy assistant
Ask Maddy about SB 3260
Scope: RI
Hi! I can help you understand SB 3260. What would you like to know?
Try one of these
i
Maddy answers using official bill text and legislative records. Always verify before sharing.
Sources cited inline